Studies in human clinical cases of CM and experiments in mouse models of P. berghei-induced CM have identified excessive TNF-a and IFN-g-driven inflammatory response as a key determinant in CM pathogenesis [2]; novel strategies to blunt this response have shown promise in the prevention and treatment of CM [35], [36], [37], [38], [39]. Here, IFNG is linked to cutaneous mastocytosis.